Document is current
Any future updates will be listed below
-
Authors
Amirkhah, Raheleh
Gilroy, Kathryn
Malla, Sudhir B. https://orcid.org/0000-0001-5862-3815
Lannagan, Tamsin R. M.
Byrne, Ryan M. https://orcid.org/0000-0001-6505-6345
Fisher, Natalie C. https://orcid.org/0000-0003-1769-7468
Corry, Shania M.
Mohamed, Noha-Ehssan
Naderi-Meshkin, Hojjat
Mills, Megan L.
Campbell, Andrew D. https://orcid.org/0000-0003-3930-1276
Ridgway, Rachel A.
Ahmaderaghi, Baharak https://orcid.org/0000-0003-4166-6290
Murray, Richard
Llergo, Antoni Berenguer https://orcid.org/0000-0002-3742-8161
Sanz-Pamplona, Rebeca
Villanueva, Alberto
Batlle, Eduard https://orcid.org/0000-0003-2422-0326
Salazar, Ramon
Lawler, Mark
Sansom, Owen J.
Dunne, Philip D. https://orcid.org/0000-0001-9160-283X
-
Funding
Funding for this research was provided by:
Cancer Research UK (A25142, A21139, A17196, A31287, A26825, A28223)
RCUK | MRC | Medical Research Foundation (MC_PC_21042)
- License Information
-
More Information
Article History
Received: 3 June 2022
Revised: 10 January 2023
Accepted: 12 January 2023
First Online: 30 January 2023
Competing interests
: OJS has received grants from Astra Zeneca, Boehringer Ingelheim, Cancer Research Horizons and Novartis, none of which are directly relevant to this study. The other authors declare no competing interests.
: All animal experiments were performed in accordance with a UK Home Office licence (Project License 70/8646), and were subject to review by the animal welfare and ethical review board of the University of Glasgow.
